Xue Han

1.1k total citations
66 papers, 743 citations indexed

About

Xue Han is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xue Han has authored 66 papers receiving a total of 743 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 11 papers in Immunology and 9 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xue Han's work include Ubiquitin and proteasome pathways (8 papers), Thyroid Cancer Diagnosis and Treatment (6 papers) and Aquatic life and conservation (5 papers). Xue Han is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Thyroid Cancer Diagnosis and Treatment (6 papers) and Aquatic life and conservation (5 papers). Xue Han collaborates with scholars based in China, Czechia and United States. Xue Han's co-authors include Guang Liang, Wu Luo, Gaojun Wu, Weijian Huang, Bozhi Ye, Jibo Han, Yi Wang, Yi Wang, Minxiu Wang and Hao Zhou and has published in prestigious journals such as PLoS ONE, The Plant Cell and Circulation Research.

In The Last Decade

Xue Han

60 papers receiving 738 citations

Peers

Countries citing papers authored by Xue Han

Since Specialization

Citations

This map shows the geographic impact of Xue Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Han more than expected).

Fields of papers citing papers by Xue Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Han. The network helps show where Xue Han may publish in the future.

Co-authorship network of co-authors of Xue Han

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Han. A scholar is included among the top collaborators of Xue Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Han. Xue Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IFN alpha signaling drives hematopoietic stem cells malfunction under acute inflammation 2025 ·International Immunopharmacology ·Xue Han, Minyi Zhao, Kexin Wang, Weiwei Ma, Binghuo Wu, Yueyang Yu, (unknown), Wenjian Mo, Xiaowei Chen, (unknown), Yumiao Li, Shilin Xu, (unknown), Yalan Yang, Peng Lei, (unknown), Shunqing Wang	0
2	Synergistic enhancement of agricultural waste biochar in Cr(III)/methylene blue co-pollutant systems: Structure regulation and co-adsorption mechanistic insights 2025 ·Journal of environmental chemical engineering ·Binqiao Ren, Xue Han, (unknown), Yuying Zhang, (unknown), Luyang Zhao, Rui Liu	1
3	Growth increase and gonadal dysfunction of the lined seahorse triggered by zinc exposure 2024 ·Aquatic Toxicology ·Xue Han, Chunyan Li, Geng Qin, (unknown), Bo Zhang, Qiang Lin	1
4	Macrophage SHP2 Deficiency Alleviates Diabetic Nephropathy via Suppression of MAPK/NF-κB– Dependent Inflammation 2024 ·Diabetes ·Xue Han, Jiajia Wei, (unknown), (unknown), (unknown), Lingfeng Chen, Zheng Xu, (unknown), Chao Zheng, Qiaojuan Shi, Huazhong Ying, Guang Liang	19
5	USP25 ameliorates vascular remodeling by deubiquitinating FOXO3 and promoting autophagic degradation of FOXO3 2024 ·Acta Pharmaceutica Sinica B ·(unknown), Bozhi Ye, (unknown), (unknown), (unknown), (unknown), Xue Han, Wu Luo, Chen Chen, Weijian Huang, Hao Zhou, Gaojun Wu, Yi Wang, Guang Liang	0
6	Carnosol attenuates angiotensin II-induced cardiac remodeling and inflammation via directly binding to p38 and inhibiting p38 activation 2024 ·International Immunopharmacology ·(unknown), Bozhi Ye, Liming Lin, (unknown), Yuchen Jiang, (unknown), (unknown), Xue Han, Wei Wang, Gaojun Wu, (unknown), Peiren Shan, Guang Liang	3
7	Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signalling pathway 2024 ·Cardiovascular Research ·Lintao Wang, Wu Luo, (unknown), Jun‐Sheng Zhang, (unknown), Yifan Shi, Li Gao, (unknown), Xiaoyan Nie, (unknown), Xue Han, Chaoyong He, Biao Xu, Guang Liang	4
8	Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses 2023 ·EMBO Molecular Medicine ·(unknown), (unknown), Xue Han, Weixin Li, Wu Luo, Liming Lin, Mingjiang Xu, Yi Wang, Weijian Huang, Gaojun Wu, Guang Liang	31
9	Linderalactone mitigates diabetic cardiomyopathy in mice via suppressing the MAPK/ATF6 pathway 2023 ·International Immunopharmacology ·Xue Han, (unknown), Jiajia Zhang, (unknown), Jiajia Wei, (unknown), Jian Zhu, (unknown), Huazhong Ying, Gaojun Wu, Qiaojuan Shi, Guang Liang	6
10	Dectin-1 Acts as a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling 2023 ·Circulation Research ·Shiju Ye, (unknown), Xue Han, Wu Luo, (unknown), Yang Ye, (unknown), (unknown), Weijian Huang, Yi Wang, (unknown), Guosheng Fu, Guang Liang	27
11	USP25 Ameliorates Pathological Cardiac Hypertrophy by Stabilizing SERCA2a in Cardiomyocytes 2023 ·Circulation Research ·Bozhi Ye, Hao Zhou, (unknown), Wu Luo, (unknown), Ying‐Yong Zhao, Jibo Han, Xue Han, Weijian Huang, Gaojun Wu, Xu Wang, Guang Liang	76
12	Deubiquitinase JOSD2 improves calcium handling and attenuates cardiac hypertrophy and dysfunction by stabilizing SERCA2a in cardiomyocytes 2023 ·Nature Cardiovascular Research ·Jibo Han, (unknown), (unknown), Bozhi Ye, (unknown), (unknown), Xue Han, Xu Wang, Gaojun Wu, Yi Wang, Guang Liang	15
13	Effects of Different Drying Methods on the Quality of Bletilla striata Scented Tea 2023 ·Molecules ·Xue Han, Zhiqin Song, Jiawei Liu, (unknown), (unknown), Hai Liu	14
14	OTUD1 promotes hypertensive kidney fibrosis and injury by deubiquitinating CDK9 in renal epithelial cells 2023 ·Acta Pharmacologica Sinica ·(unknown), (unknown), (unknown), Xue Han, Xiang Hu, Shiju Ye, (unknown), Yi Wang, Hong Zhu, Wu Luo, Guang Liang	9
15	Ultrasound-guided microwave ablation in the treatment of recurrent primary hyperparathyroidism in a patient with MEN1: a case report 2023 ·Frontiers in Endocrinology ·(unknown), (unknown), Xue Han, Xin Hu, Yuzhi Zhang, (unknown), Guofang Chen, Chao Liu, Shuhang Xu	1
16	Sclareol ameliorates hyperglycemia‐induced renal injury through inhibiting the MAPK / NF‐κB signaling pathway 2022 ·Phytotherapy Research ·Xue Han, Jiajia Zhang, Li Zhou, Jiajia Wei, (unknown), Qiaojuan Shi, (unknown), Juan Ren, Yi Wang, Huazhong Ying, Guang Liang	20
17	Curcumin analog JM-2 alleviates diabetic cardiomyopathy inflammation and remodeling by inhibiting the NF-κB pathway 2022 ·Biomedicine & Pharmacotherapy ·Minxiu Wang, (unknown), Qianhui Zhang, Weiwei Zhu, (unknown), (unknown), Wu Luo, Xue Han, Guang Liang	15
18	Regulatory Role of Retinoic Acid in Male Pregnancy of the Seahorse 2020 ·The Innovation ·Chunyan Li, Yong‐Xin Li, Geng Qin, Zelin Chen, Meng Qu, Bo Zhang, Xue Han, Xin Wang, Pei‐Yuan Qian, Qiang Lin	18
19	MS5 Mediates Early Meiotic Progression and Its Natural Variants May Have Applications for Hybrid Production in Brassica napus 2016 ·The Plant Cell ·Qiang Xin, Yi Shen, Xi Li, Wei Lü, Xiang Wang, Xue Han, Faming Dong, Lili Wan, Guangsheng Yang, Dengfeng Hong, Zhukuan Cheng	29
20	Development and Characterization of Monoclonal Antibodies Against Mouse TSLP 2010 ·Hybridoma ·Xiangqun Li, Xue Han, Shengdian Wang, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact